Literature DB >> 7237311

Use of propranolol in treating tardive dyskinesia.

T R Einarson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7237311      PMCID： PMC1705432     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Efficacy of chronic propranolol therapy in action tremors of the familial, senile or essential varieties.

Authors:  G F Winkler; R R Young
Journal:  N Engl J Med       Date:  1974-05-02       Impact factor: 91.245

2.  Effect of the beta adrenergic blocking agent propranolol on essential tremor.

Authors:  M H Morgan; R L Hewer; R Cooper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-08       Impact factor: 10.154

3.  Essential (familial, hereditary) tremor: a case report.

Authors:  E Herskovits; W Blackwood
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-12       Impact factor: 10.154

4.  Metoprolol in essential tremor.

Authors:  D Jefferson; C D Marsden
Journal:  Lancet       Date:  1980-02-23       Impact factor: 79.321

5.  Low-dose propranolol in tardive dyskinesia.

Authors:  N M Bacher; H A Lewis
Journal:  Am J Psychiatry       Date:  1980-04       Impact factor: 18.112

6.  Clinical manifestations of essential tremor.

Authors:  E Critchley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-06       Impact factor: 10.154
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.